BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Palmer CB, D'uonnolo G, Luís R, Meyrath M, Uchański T, Chevigné A, Szpakowska M. Nanoluciferase-based complementation assay for systematic profiling of GPCR–GRK interactions. Biomolecular Interactions Part B 2022. [DOI: 10.1016/bs.mcb.2022.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Zhang X, Shi X, Liu Y, Chen D, Tian Q, Lin N, Wei W, Wu H. CXCL9, 10, 11/CXCR3 axis contributes to the progress of primary Sjogren's syndrome by activating GRK2 to promote T lymphocyte migration.. [DOI: 10.21203/rs.3.rs-2384219/v1] [Reference Citation Analysis]
2 Meyrath M, Szpakowska M, Plesseria J, Domingues O, Langlet J, Weber B, Krüger R, Ollert M, Chevigné A. Nanoluciferase-based cell fusion assay for rapid and high-throughput assessment of SARS-CoV-2-neutralizing antibodies in patient samples. Methods in Enzymology 2022. [DOI: 10.1016/bs.mie.2022.07.015] [Reference Citation Analysis]
3 Dosquet H, Neirinckx V, Meyrath M, Wantz M, Haan S, Niclou SP, Szpakowska M, Chevigné A. Nanoluciferase-based complementation assays to monitor activation, modulation and signaling of receptor tyrosine kinases (RTKs). Methods in Enzymology 2022. [DOI: 10.1016/bs.mie.2022.09.002] [Reference Citation Analysis]